N-Feruloylserotonin inhibits lipopolysaccharide-induced inflammation via SIRT1-stimulated FOXO1 and NF-κB signaling pathways in RAW 264.7 cells

Cell Mol Biol (Noisy-le-grand). 2023 Nov 15;69(11):109-115. doi: 10.14715/cmb/2023.69.11.17.

Abstract

Macrophages become activated by a variety of stimuli such as lipopolysaccharide (LPS) and participate in the process of immune responses. Activated macrophages produce various inflammatory mediators. In the present study, we investigated the anti-inflammatory mechanism of a serotonin derivative, N-feruloylserotonin, isolated from safflower seeds in RAW 264.7 macrophages. N-Feruloylserotonin treatment significantly attenuated these effects on LPS-induced reactive oxygen species, nitric oxide, and prostaglandin E2 production in RAW 264.7 macrophages. Furthermore, N-feruloylserotonin significantly decreased the abnormal expression of mitogen-activated protein kinase, such as phosphor (p)-c-Jun N-terminal kinase and p-extracellular-signal regulated kinase activation. Further research revealed that N-feruloylserotonin could stimulate sirtuin1 (SIRT1), then promote the forkhead box protein O1 (FOXO1), and suppress nuclear factor-kappa B (NF-kB) signaling pathways. The present study suggests that N-feruloylserotonin may be a new anti-inflammatory component and a promising candidate for anti-inflammatory therapeutic agents through the regulation of SIRT1-stimulated FOXO1 and NF-kB signaling pathways.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Inflammation / chemically induced
  • Inflammation / drug therapy
  • Lipopolysaccharides* / toxicity
  • Mice
  • NF-kappa B*
  • RAW 264.7 Cells
  • Serotonin / pharmacology
  • Signal Transduction
  • Sirtuin 1

Substances

  • NF-kappa B
  • Lipopolysaccharides
  • N-feruloylserotonin
  • Serotonin
  • Sirtuin 1
  • Anti-Inflammatory Agents